- $111.42m
- $468.76m
- $572.43m
- 61
- 87
- 70
- 84
C2019 September 30th | 2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 43.6 | 60.5 | 89.6 | 548 | 572 |
Cost of Revenue | |||||
Gross Profit | 14 | 18.2 | 30.2 | 157 | 165 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 43.8 | 63.5 | 95.2 | 811 | 654 |
Operating Profit | -0.153 | -3.06 | -5.62 | -263 | -81.5 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.786 | -4.54 | 6.12 | -352 | -124 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.79 | -4.68 | 10.9 | -337 | -105 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -0.79 | -4.68 | 10.9 | -337 | -105 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.79 | -4.68 | 10.9 | -337 | -105 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.076 | -0.432 | 0.786 | -6.11 | -2.1 |